Beleave Inc (CSE:BE)

Summary

Formed by nature, perfected by science. We’re bridging science and tradition to bring you remarkable cannabis products.

Market Overview

Company Background

Beleave is a vertically-integrated Canadian cannabis company headquartered in Oakville, Ontario, that operates streamlined facilities throughout Canada to cultivate high-quality cannabis flower, oil, and extracts with funded capacity in excess of 150,000 kg per year.Fully-licensed to cultivate and sell medical and recreational cannabis, Beleave is leading the way through research partnerships with universities to bridge the gap between science and tradition and to develop pharma-grade extracts and derivatives. Beleave is currently developing new product lines for October 2019 as the recreational market is expected to allow for food and beverage-based cannabis products.Beleave is growing its storefront and online sales presence rapidly through its wholly-owned subsidiaries, Beleave Kannabis Corp. and Seven Oaks, which are licensed for medicinal and recreational sales respectively. The company's first retail location is opening this fall in Lloydminster, Saskatchewan. Beleave has also developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner.Through its majority ownership of Procannmed S.A.S., Beleave has access to 27 hectares of outdoor grow space and is fully licensed to cultivate, produce, extract and distribute medical cannabis in Colombia to capitalize on exports and the expanding Latin American market.

Highlights

Production Capacity (Total production capacity 1,731,500 SQ FT at 2020)
  1. Hamilton Indoor Production - 14,500 SQ FT- open now
  2. London Greenhouse Production - 250,000 SQ FT - early 2019
  3. London Outdoor Production - 600,000 SQ FT - early 2019
  4. British Columbia Indoor Production - 867,000 SQ FT - mid-late 2019
Product Development
  1. Patenting Solubility
  2. Solving Bio-Availability
  3. Patenting Extraction
Sales and Distribution
  1. Provincial supply agreements with access to over 55% of the Canadian population
  2. Strategy to capitalize on international opportunities- undertaking negotiations to supply major EU and Colombia markets
  3. Diversified house of brands, able to serve large and niche markets alike
House of Brands
  1. Authentic brands that stand out with creative marketing, attractive packaging and memorable online and in-store buying experiences for highly targeted groups of individuals

Share Structure

As of Oct 5, 2018
Shares Issued59,291,313
Common Shares Outstanding14,086,721
Fully Diluted73,378,034

Other Information

Products:

Vertical Supply Chain
  • Product Development Built on Research
  • Production Capacity
  • Sales and Distribution
  • Retail Expansion

Management Profiles

Andrew T. Wnek CA, CPA, B.COMM, MBA

Chief Executive Officer, Director

Andrew offers significant retail, oil and gas, and not-for-profit industry experience translated from a robust twenty-one year career, including leading large multi-layered projects with corporate giant, Canadian Tire. His vision for Beleave is coming to fruition with a powerhouse team in motion.

Bojan Krasic, MIM

President, Chief Financial Officer, Director

Bojan was responsible for leading strategy, business development, M&A transactions for Beleave. With well over a decade of career development, Bojan offers wide ranging financial expertise built with Thomas Weisel Partners Canada Inc., Stifel Nicolaus Canada Inc., and later serving as CEO of Terrella Capital and is a board member of public and private companies.

Bill Panagiotakopoulos

Chief Operational Officer, Director

Bill was an early mover in Canada’s cannabis sector and has contributed significantly to successfully navigating the regulatory framework to obtain a cannabis production and sales license. Bill was the founder and owner of Cardinal Group Inc, specializing in evaluating opportunities and helping set strategic goals in business development.

Roger Ferreira, Ph.D.

Chief Science Officer, Director

Roger leads Beleave's science and innovation program and offers substantial experience in laboratory management (University of Toronto & Toronto University Health Network) and his PhD training in the area of neuroimmunology.

Do NOT follow this link or you will be banned from the site!